Format

Send to

Choose Destination
See comment in PubMed Commons below
Antiviral Res. 2007 Feb;73(2):112-7. Epub 2006 Aug 28.

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

Author information

1
WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Road, Parkville, Melbourne 3052, Australia. Ian.Barr@influenzacenter.org

Abstract

The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005.

PMID:
16963130
DOI:
10.1016/j.antiviral.2006.08.002
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center